Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms.
Kang S, Kishimoto T. · 2021
Read Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. by Kang S, Kishimoto T. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8273570.txt.
Description
Kang and Kishimoto survey interleukin-6 signalling and the vessel wall in cytokine storms. IL-6 defends the body against infection and injury. It also marks several kinds of cytokine storm.
IL-6 acts directly on vascular endothelial cells. Those cells then release more cytokines and start clotting paths. Leaky vessels and abnormal clotting mark severe storms. A humanised antibody, tocilizumab, blocks the IL-6 receptor. Evidence suggests it can quiet IL-6 signalling in patients. The review ties cell biology to that therapy. It clarifies when blocking IL-6 should help most. Vessel failure is treated as a driver, not a bystander.
Catalog record
| CREATOR | Kang S, Kishimoto T. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |